Is the minimally clinically important difference (MCID) fit for purpose? A planned study using the SAQ

J. Lanario (Plymouth, United Kingdom), R. Jones (Plymouth, United Kingdom), M. Hyland (Plymouth, United Kingdom), A. Menzies-Gow (London, United Kingdom), A. Mansur (Birmingham, United Kingdom), J. Dodd (Bristol, United Kingdom), S. Fowler (Manchester, United Kingdom), M. Patel (Plymouth, United Kingdom), G. Hayes (Plymouth, United Kingdom), M. Masoli (Exeter, United Kingdom)

Source: Virtual Congress 2020 – Clinical parameters in severe asthma
Session: Clinical parameters in severe asthma
Session type: E-poster session
Number: 2241
Disease area: Airway diseases

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
J. Lanario (Plymouth, United Kingdom), R. Jones (Plymouth, United Kingdom), M. Hyland (Plymouth, United Kingdom), A. Menzies-Gow (London, United Kingdom), A. Mansur (Birmingham, United Kingdom), J. Dodd (Bristol, United Kingdom), S. Fowler (Manchester, United Kingdom), M. Patel (Plymouth, United Kingdom), G. Hayes (Plymouth, United Kingdom), M. Masoli (Exeter, United Kingdom). Is the minimally clinically important difference (MCID) fit for purpose? A planned study using the SAQ. 2241

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Minimal clinically important difference of the clinical COPD questionnaire
Source: Eur Respir J 2004; 24: Suppl. 48, 689s
Year: 2004

Minimal clinically important difference for asthma endpoints: an expert consensus report
Source: Eur Respir Rev, 29 (156) 190137; 10.1183/16000617.0137-2019
Year: 2020



Minimal clinically important differences for Dyspnea-12 and MDP scores are similar at 2 weeks and 6 months: follow-up of a longitudinal clinical study
Source: Eur Respir J, 57 (3) 2002823; 10.1183/13993003.02823-2020
Year: 2021



Is the CURB65 score fit for purpose - a retrospective analysis
Source: International Congress 2017 – CAP: severity scores, risk groups and biomarkers
Year: 2017

The minimal clinically important difference for COPD health status tools measured with global ratings of change during different time periods
Source: International Congress 2016 – Managing multimorbidity and lifestyle change in primary care
Year: 2016


Which method is effective in patient with asthma to guide the treatment? (2 year follow-up study)
Source: Annual Congress 2009 - Quality of treatment in primary respiratory care
Year: 2009

The Severe Asthma Questionnaire (SAQ) - minimal clinically important difference and sensitivity to change
Source: Virtual Congress 2021 – Patient-reported outcome measures (PROMs): easy tools in the management of chronic respiratory diseases
Year: 2021



A questionnaire specifically designed for Italian patients affected by COPD. Criteria to choice the optimal number of items using simple logistic models
Source: Eur Respir J 2003; 22: Suppl. 45, 56s
Year: 2003

The development of an instrument to assess the needs of people with COPD: a Delphi study
Source: International Congress 2018 – The many facets of respiratory nursing
Year: 2018




The incremental shuttle walk test (ISW) in patients with bronchiectasis: Response to pulmonary rehabilitation (PR) and minimum clinically important difference (MCID)
Source: International Congress 2019 – Hot topics in pulmonary rehabilitation
Year: 2019

Evaluation of a method for establishing biologic quality control ranges from the first 20 acceptable test sessions in a large multi-center study
Source: Annual Congress 2009 - Quality control in lung function and new developments
Year: 2009


The EQ5D5L in COPD: Validity, responsiveness and minimum important difference (MID)
Source: International Congress 2015 – Latest insights into pulmonary rehabilitation
Year: 2015


Responsiveness and minimal clinically important difference of K-BILD and SGRQ-I
Source: Virtual Congress 2020 – Clinical aspects of idiopathic pulmonary fibrosis
Year: 2020


Comprehensive comparison of the repeatability of the most commonly employed tests of exercise performance for patients with stable COPD.  An observational study.
Source: International Congress 2018 – Let’s interact and discuss the hot topics in pulmonary rehabilitation
Year: 2018



DES-OSA PLUS- a validation study and improvement of the score
Source: International Congress 2018 – Diagnostics including questionnaires
Year: 2018

Could step and stepper tests be valid to assessing the exercise and functional capacities in patients with COPD? Results from a systematic review.
Source: Virtual Congress 2020 – Tapas of respiratory physiotherapy
Year: 2020


Monitoring quality of life (QOL) in patients undergoing diagnostic or therapeutic bronchoscopic intervention: a pilot study
Source: Eur Respir J 2003; 22: Suppl. 45, 430s
Year: 2003

Minimal important difference for the asthma control questionnaire
Source: Eur Respir J 2004; 24: Suppl. 48, 460s
Year: 2004

Asthma cost-effectiveness analyses: Are we using the recommended outcomes in estimating value?
Source: International Congress 2017 – Primary care management of asthma and self-management of respiratory disease
Year: 2017

Development and pilot testing of a new 7-item cough severity patient reported outcome measure
Source: Annual Congress 2008 - COPD epidemiology
Year: 2008